Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 155,300 shares at $165.93 ($25.7M) on 2023-02-09, disclosed to the SEC on 2023-02-10.
Seasonal sale ($25.7M) by Chief Executive Officer — this insider has traded MRNA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $164.65 | 9,589 | $1.6M | 6.1% |
| 2 | $164.65 | 9,589 | $1.6M | 6.1% |
| 3 | $165.77 | 19,648 | $3.3M | 12.7% |
| 4 | $165.77 | 19,648 | $3.3M | 12.7% |
| 5 | $166.51 | 4,543 | $756K | 2.9% |
| 6 | $166.51 | 4,543 |
| $756K |
| 2.9% |
| 7 | $168.01 | 2,772 | $466K | 1.8% |
| 8 | $168.01 | 2,772 | $466K | 1.8% |
| 9 | $168.64 | 2,848 | $480K | 1.9% |
| 10 | $168.64 | 2,848 | $480K | 1.9% |
| 11 | $169.40 | 600 | $102K | 0.4% |
| 12 | $165.04 | 24,628 | $4.1M | 15.8% |
| 13 | $165.04 | 24,628 | $4.1M | 15.8% |
| 14 | $165.93 | 11,272 | $1.9M | 7.3% |
| 15 | $165.93 | 11,272 | $1.9M | 7.3% |
| 16 | $166.86 | 1,600 | $267K | 1.0% |
| 17 | $168.26 | 2,100 | $353K | 1.4% |
| 18 | $169.01 | 400 | $68K | 0.3% |
| Total | $165.72 avg | 155,300 | $25.7M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |